Cytokines as a predictor of COVID-19 severity: evidence from meta-analysis.

[1]  Shengdian Wang,et al.  Neutrophil‐to‐lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID‐19 , 2020, International journal of laboratory hematology.

[2]  J. M. Urra,et al.  High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19 , 2020, Molecular Immunology.

[3]  S. Antony,et al.  Risk factors for mortality among patients with SARS‐CoV‐2 infection: A longitudinal observational study , 2020, Journal of medical virology.

[4]  N. Tang,et al.  Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study , 2020, Clinical and Experimental Medicine.

[5]  Q. Ning,et al.  Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China , 2020, Critical Care.

[6]  Fu-Sheng Wang,et al.  Predictors of coronavirus disease 2019 severity: A retrospective study of 64 cases. , 2020, Japanese journal of infectious diseases.

[7]  Yu-Qing Cai,et al.  Association between cytokine profiles and lung injury in COVID-19 pneumonia , 2020, Respiratory Research.

[8]  T. Kuno,et al.  The association of interleukin‐6 value, interleukin inhibitors, and outcomes of patients with COVID‐19 in New York City , 2020, Journal of medical virology.

[9]  Mengyu Zhang,et al.  Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China , 2020, International journal of medical sciences.

[10]  Wei Wang,et al.  Hyperglycemia is a strong predictor of poor prognosis in COVID-19 , 2020, Diabetes Research and Clinical Practice.

[11]  O. Cabrera-Marante,et al.  IL-6–based mortality risk model for hospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[12]  N. M. Mutlu,et al.  COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in Turkey , 2020, Turkish journal of medical sciences.

[13]  Mario Guarino,et al.  Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19). , 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[14]  J. Bao,et al.  Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China , 2020, Archives of Gerontology and Geriatrics.

[15]  Yadan Wang,et al.  Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study , 2020, The Lancet Haematology.

[16]  M. Antonelli,et al.  Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort , 2020, EClinicalMedicine.

[17]  Qianqian Wan,et al.  Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes , 2020, Journal of Diabetes and its Complications.

[18]  Fang Lin,et al.  Clinical and pathological investigation of patients with severe COVID-19 , 2020, JCI Insight.

[19]  Changhui Wang,et al.  Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19). , 2020, Circulation journal : official journal of the Japanese Circulation Society.

[20]  Xiaowei Yan,et al.  Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study , 2020, Scientific Reports.

[21]  Z. Lv,et al.  Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, Microbes and Infection.

[22]  W. Liang,et al.  Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China , 2020, Journal of Allergy and Clinical Immunology.

[23]  Fu-Sheng Wang,et al.  Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience , 2020, Journal of Autoimmunity.

[24]  Zhe Zhu,et al.  Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 , 2020, International Journal of Infectious Diseases.

[25]  Fang Liu,et al.  Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 , 2020, Journal of Clinical Virology.

[26]  Ke Liang,et al.  Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  B. Zwissler,et al.  Coronavirus disease 2019 , 2020, Der Anaesthesist.

[28]  Lei Liu,et al.  The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients , 2020, Inflammation Research.

[29]  Xiuyong Li,et al.  Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 , 2020, Journal of medical virology.

[30]  Q. Zeng,et al.  Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population , 2020, medRxiv.

[31]  Gang Wu,et al.  The potential role of IL-6 in monitoring severe case of coronavirus disease 2019 , 2020, medRxiv.

[32]  Lei Liu,et al.  Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome , 2020, medRxiv.

[33]  Dong Men,et al.  Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients , 2020, medRxiv.

[34]  Lei Liu,et al.  Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,China , 2020 .

[35]  L. Lei,et al.  Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China , 2020, medRxiv.

[36]  Lei Liu,et al.  COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China , 2020, medRxiv.

[37]  Lijuan Xiong,et al.  Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients , 2020, EBioMedicine.

[38]  A. Pirat,et al.  PREDICTORS OF INTENSIVE CARE UNIT ADMISSION IN GERIATRIC PATIENTS UNDERGOING HIP REPLACEMENT: 267 , 2004 .

[39]  Daishi Tian,et al.  Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China , 2020 .